We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Breakthrough Device That Detects DNA with 100-Fold Greater Sensitivity to Speed Disease Detection

By LabMedica International staff writers
Posted on 05 Oct 2023

Traditional DNA detection methods are like searching for a needle in a haystack, given that there are many other molecules in a sample that are not the target DNA and can interfere with the result. More...

Now, a new method for DNA detection offers 100-fold greater sensitivity than traditional methods, paving the way for faster disease detection at the point of care.

In the new DNA detection method developed by researchers at the University of Massachusetts Amherst (Amherst, MA, USA), the test sample is placed within an alternating electric field, allowing the DNA strands to "dance." Each strand moves with its own unique frequency of oscillation. Researchers can then examine the sample to find a molecule that moves just like the DNA they're looking for, making it easy to identify even when present in extremely low concentrations.

The implications for this groundbreaking method are enormous, particularly for early diagnosis of diseases. Because of its high sensitivity, the test can identify diseases much sooner in their progression, which can be critical for treatment. Moreover, the electric-based method yields results in minutes rather than days, weeks, or months, making it ideal for point-of-care settings. Additionally, the technology is highly portable, resembling the size of a blood sugar monitoring device, which has the potential to make a substantial impact on global health.

“Everyone wants to detect the DNA at a low concentration with a high sensitivity. And we just developed this method to improve the sensitivity by about 100 times with no cost,” said Jinglei Ping, lead author of the paper that appeared in Proceedings of the National Academy of Sciences. “The nano-mechanoelectrical approach can be also integrated with other bioengineering technologies, like CRISPR, to elucidate nucleic acid signaling pathways, comprehend disease mechanisms, identify novel drug targets and create personalized treatment strategies, including microRNA-targeted therapies.”

Related Links:
UMass Amherst


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.